IMMU-09. NIVOLUMAB THERAPY FOR A PEDIATRIC-ONSET PRIMARY INTRACRANIAL MELANOMA

Primary intracranial malignant melanoma (PIMM) is an uncommon cancer in childhood, that accounts for approximately 1% of melanoma, and 0.07% of brain tumors even in all age group. Because extracranial malignant melanoma usually occurs as a cutaneous lesion, affected patients have a chance to receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Oba, Utako, Koga, Yuhki, Kawaguchi, Riichiro, Nakashima, Kentaro, Akagi, Yojiro, Hata, Nobuhiro, Yamamoto, Nanae, Kohashi, Kenichi, Masuda, Satohiro, Iihara, Koji, Oda, Yoshinao, Ohga, Shouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715568/
http://dx.doi.org/10.1093/neuonc/noaa222.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715568/
http://dx.doi.org/10.1093/neuonc/noaa222.365

Ejemplares similares